News
Category
-
GlobeNewswire
Precision BioSciences Appoints David Thomson, PhD, as Chief Operating Officer
September 23, 2019 -
Business Wire
Nebula Genomics Launches Anonymous Genetic Testing
September 19, 2019 -
LA Business Journal
Hospitality Startup AvantStay Raises $20 Million
September 19, 2019 -
PR Newswire
Innovent Provides Update on the Results of IBI305 for the First-line Treatment of Advanced Non-squamous Cell Lung Cancer by Oral Presentation at CSCO
September 19, 2019 -
PR Newswire
Benchling Launches New Products for Research Institutions and Biotech Startups to Accelerate Life Science Innovation
September 17, 2019 -
genomeweb
LunaPBC Partners With Medfusion to Integrate EHR, Genomic Data-Sharing Platform
September 17, 2019 -
PR Newswire
Firefly Health Closes $10.2 Million Series A Funding Round to Expand New Primary Care and Patient Experience Platform
September 16, 2019 -
GlobeNewswire
Precision BioSciences Announces FDA Clearance of the IND for PBCAR20A, a CD20 Targeting Genome Edited Allogeneic CAR T Therapy
September 16, 2019 -
Business Wire
Verve Therapeutics Appoints Drug Delivery Expert Andrew Geall, Ph.D., to Scientific Advisory Board
September 16, 2019 -
Business Wire
Devoted Health and Publix Team Up to Improve Flu Vaccination Coverage in Florida
September 12, 2019 -
GlobeNewswire
Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) in Tumor-Induced Osteomalacia (TIO)
September 10, 2019 -
BioSpectrum
Insilico Medicine secures $37M in series B funding
September 10, 2019 -
PR Web
CareStack and ClearGage Announce Technology Integration
September 10, 2019 -
GlobeNewswire
Zogenix Completes Acquisition of Modis Therapeutics, Inc.
September 9, 2019 -
GlobeNewswire
United States Orphan Drug Designation for Treatment of Soft Tissue Sarcomas Granted to SPEAR T-cells Targeting MAGE-A4
September 9, 2019 -
Fierce Biotech
Insilico’s AI networks generate custom lead compounds for fibrosis in less than 50 days
September 4, 2019 -
GlobeNewswire
Ultragenyx Announces Positive Data from Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia
September 4, 2019 -
GlobeNewswire
Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL151 for Parkinson’s Disease and Launch of Its Engage Parkinson’s Website
September 4, 2019 -
VentureBeat
Even Financial raises $25 million to connect banks with channel partners
September 4, 2019 -
GlobeNewswire
Orchard Therapeutics Announces Encouraging Update from Proof-of-Concept Study of OTL-203 for the Treatment of Mucopolysaccharidosis Type I (MPS-I)
September 4, 2019 -
Business Wire
Beam Therapeutics Appoints Financial Industry Veteran, Terry-Ann Burrell, as Chief Financial Officer
September 4, 2019 -
Business Wire
Iora Health and Humana Expand Relationship to Provide More Humana Medicare Advantage Plan Members Access to Additional Coordinated Care in Arizona, Georgia and Texas
September 4, 2019 -
Fierce Biotech
Biotech Vertex plunks down $950M for stem cell player Semma Therapeutics
September 3, 2019 -
GlobeNewswire
GeneTx and Ultragenyx Announce Orphan Drug Designation and Rare Pediatric Disease Designation for GTX-102
September 3, 2019 -
GlobeNewswire
Flywire and VPBank Partner on International Tuition Payments for Vietnamese Students
August 29, 2019 -
GlobeNewswire
Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
August 27, 2019 -
PR Newswire
Iora Primary Care to Open Five Practices Offering Quality Care for Adults on Medicare
August 26, 2019 -
Fierce Biotech
Zogenix pays $250M upfront for startup Modis and its FDA ‘breakthrough’ med
August 26, 2019 -
Endpoint News
Modis Therapeutics -$30M launch round to $400M buyout deal — with $250M upfront — in 10 short months
August 26, 2019 -
PR Newswire
Avidity Biosciences Adds Drug Development Veterans Edward Kaye and Noreen Henig to Board of Directors
August 22, 2019 -
PR Newswire
Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
August 21, 2019 -
Newswire
Healthcare Embracing New Era of Compliance and Analytics
August 20, 2019 -
TechCrunch
Simon Data hauls in $30M Series C to continue building customer data platform
August 20, 2019 -
STAT
Can targeting one protein complex solve multiple diseases? NodThera is betting on it
August 16, 2019 -
PR Newswire
Vitalware Named to the 2019 Inc. 5000 Fastest Growing Private Companies List for Fifth Consecutive Year
August 15, 2019 -
GlobeNewswire
Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
August 14, 2019 -
PR Newswire
Iora Health Hires New Chief Operating Officer, Suzanne Hansen
August 13, 2019 -
Business Wire
Kyruus ProviderMatch® Patient Access Platform Now Powering Patient-Provider Matching at Norton Healthcare
August 6, 2019 -
TechCrunch
Optimus Ride’s Brooklyn self-driving shuttles begin picking up passengers this week
August 6, 2019 -
PR Newswire
Innovent and Shenogen Announce Collaboration to Evaluate Tyvyt® (Sintilimab injection) in Combination with SNG1005 for the Treatment of Patients with Advanced Cancer
August 5, 2019 -
GlobeNewswire
Ultragenyx Announces Submission of New Drug Application to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation Disorders
August 1, 2019 -
PR Newswire
Orchard Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for OTL-103 for the Treatment of Wiskott-Aldrich Syndrome
July 29, 2019 -
GlobeNewswire
Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS
July 25, 2019 -
Crunchbase News
Toast Acquires StratEx To Help Restaurants Retain Employees
July 24, 2019 -
PR Newswire
First Patient Dosed in Sintilimab and Anti-VEGF Monoclonal Antibody IBI305 with Chemotherapy in Patients with EGFR-mutant Non-squamous NSCLC who have Progressed from Prior EGFR-TKI Treatment
July 24, 2019 -
PR Newswire
Benchling Raises $34.5M Series C To Fuel Life Sciences R&D
July 24, 2019 -
GlobeNewswire
Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer
July 22, 2019 -
GlobeNewswire
Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center
July 22, 2019 -
Business Standard
Caplin Steriles gets USFDA approval for Tranexamic Acid Injection
July 18, 2019 -
GlobeNewswire
Apellis Pharmaceuticals Will Commence APL-9 Program to Control the Complement System in Host Responses to AAV Vector Administration for Gene Therapies
July 18, 2019 -
PR Newswire
TraceLink Partners With Excellis to Provide Local Implementation Services for its Russia Compliance Solution Through One Global Compliance Platform
July 18, 2019 -
GlobeNewswire
Precision BioSciences Opens First In-House cGMP Manufacturing Facility Dedicated to Genome-Edited Allogeneic CAR T Cell Therapy in the United States
July 18, 2019 -
GlobeNewswire
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
July 18, 2019 -
GlobeNewswire
Acacia Pharma Founder Dr. Julian Gilbert steps down – Michael Bolinder, Chief Commercial Officer, becomes CEO in Planned Succession
July 18, 2019 -
PR Newswire
Protenus Named 2019 Top Patient Privacy Solution by Black Book Market Research
July 11, 2019 -
PR Newswire
Embark Unleashes New, Best In Class Canine DNA Breed Identification Kit
July 9, 2019 -
Business Wire
TriHealth Enhances Its Consumer Access Experience with Patient-Provider Matching Solution from Kyruus
July 9, 2019 -
GlobeNewswire
Pulmocide announces Scientific Reports (Nature Research) publication showing PC945 in combination with standard antifungal treatment causes a synergistic effect against Aspergillus fumigatus
July 2, 2019 -
PR Newswire
LunaPBC Named 2019 World Economic Forum Technology Pioneer
July 1, 2019 -
Business Wire
Semma Therapeutics Announces Pre-Clinical Proof-of-Concept in Two Lead Programs in Type 1 Diabetes
July 1, 2019 -
Nasdaq
Apellis Pharmaceuticals Completes Enrollment of Phase 3 APL-2 (pegcetacoplan) Head-to-Head Study in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab
June 27, 2019 -
PR Newswire
Novaerus Joins Clean Hospitals
June 20, 2019 -
Zacks Equity Research
Ultragenyx & Arcturus Therapeutics Expand Existing Agreement
June 20, 2019 -
Business Wire
Kyruus and Brandify Form Partnership to Help Health Systems Boost Brand Visibility and Patient Acquisition Online
June 18, 2019 -
Business Wire
Compass Therapeutics Announces Issuance of Composition of Matter and Method Patents Covering Its Lead Immuno-oncology Candidate, CTX-471
June 17, 2019 -
PR Newswire
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at 2019 ASCO and EHA Annual Meetings
June 17, 2019 -
Business Wire
Innovusion Announces Its High-Resolution Image-Grade LiDAR System “Cheetah”, Enabling the Safest Performance in the Vehicle Mobility Industry
June 14, 2019 -
Business Wire
Signaling Industry-Wide Shift to Integrated Mental Health, Quartet Announces Capital Raise and Strategic Partnership with Leading Medicaid Provider
June 13, 2019 -
GlobeNewswire
Unum Therapeutics Strengthens and Expands Leadership Team
June 13, 2019 -
PR Newswire
Akrevia Therapeutics Appoints Joseph Farmer as Chief Operating Officer
June 12, 2019 -
GlobeNewswire
Precision BioSciences Appoints Dario Scimeca as General Counsel
June 12, 2019 -
MobiHealthNews
Nebula Genomics, Merck KGaA’s EMD Serono partner on lung cancer pilot
June 11, 2019 -
Business Wire
Ivenix Infusion System Receives FDA 510(k) Clearance; Poised to Revolutionize the Infusion Pump Industry
June 11, 2019 -
GlobeNewswire
Denali Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designation for DNL310, and Expands its Portfolio of Brain Penetrant Enzyme Replacement Programs
June 11, 2019 -
Business Wire
Kyruus ProviderMatch® for Consumers in Spanish Wins Patient Engagement Innovation Award
June 5, 2019 -
Business Wire
Darby Dental Supply Announces Partnership with CareStack®, Further Expanding Suite of Technology Solutions
June 5, 2019 -
GlobeNewswire
Orchard Therapeutics Announced Pricing of Public Offering
June 5, 2019 -
Business Insider
Hua Medicine – Business & Pipeline Update
June 4, 2019 -
PR Newswire
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin’s Lymphoma
June 3, 2019 -
Business Wire
Beam Therapeutics and Bio Palette Announce Exclusive License Agreements for Base Editing Technologies
May 31, 2019 -
PR Newswire
Innovent Provides Update on Phase Ib Study of Sintilimab in Combination with Chemotherapy for First-line Advanced or Metastatic Non-small Cell Lung Cancer
May 30, 2019 -
BioSpace
Ultragenyx Announces Emil D. Kakkis, M.D., Ph.D. as Recipient of BIO’s 2019 Henri A. Termeer Biotechnology Visionary Award
May 29, 2019 -
PR Newswire
Former Advertising.com and AOL Executive Joins Protenus Team
May 22, 2019 -
PR Newswire
Akrevia Therapeutics Appoints René Russo, PharmD, as Chief Executive Officer
May 22, 2019 -
Crain's Chicago Business
Insure-tech provider Snapsheet raises $29 million
May 21, 2019 -
PR Newswire
Protenus Named a 2019 ‘Cool Vendor’ in Healthcare Artificial Intelligence by Gartner
May 20, 2019 -
PR Newswire
UCB announces NAYZILAM® (midazolam) nasal spray now approved by FDA to treat intermittent, stereotypic episodes of frequent seizure activity in people living with epilepsy in the U.S.
May 20, 2019 -
PR Newswire
Akrevia Therapeutics Appoints Distinguished Research Leaders to Scientific Advisory Board
May 16, 2019 -
Business Wire
Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist
May 16, 2019 -
GlobeNewswire
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
May 15, 2019